Skip to main content

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis

Include preview-only content
  1. Article

    Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

    Mitchell Levy, Marcel Levi, Mark D. Williams, Massimo Antonelli in Intensive Care Medicine (2009)

  2. Article

    Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

    The safety of using heparin concomitantly with drotrecogin alfa (activated) {DrotAA} was explored in the XPRESS study. No heparin effect on mortality was observed. Safety results from that study are explored i...

    Mitchell Levy, Marcel Levi, Mark D. Williams, Massimo Antonelli in Intensive Care Medicine (2009)

  3. Article

    What do sepsis-induced coagulation test result abnormalities mean to intensivists?

    Marcel Levi, Marcus J. Schultz in Intensive Care Medicine (2017)